LIM激酶2与Jun氨基末端激酶抑制剂联合应用改善海绵体神经损伤大鼠模型的勃起功能
研究将60只12周龄雄性Sprague-Dawley大鼠分为假手术组、海绵体神经挤压伤(CNCI)组、CNCI+10.0 mg/kg LIMK2抑制剂联合低剂量(1.0 mg/kg)JNK抑制剂组、CNCI+10.0 mg/kg LIMK2抑制剂联合高剂量(10.0 mg/kg)JNK抑制剂组,术后10天评估勃起反应、组织学和Western blot。结果显示CNCI组较假手术组出现勃起功能下降及凋亡、纤维化相关分子改变,两个联合治疗组均见改善,高剂量JNK组改善趋势更明显。作者认为联合抑制JNK和LIMK2可能通过恢复cJun/Bcl-2/Bax和LIMK2/Cofilin通路抑制海绵体凋亡和纤维化,从而改善勃起功能。
要点
- CNCI组较假手术组最大ICP/MAP和AUC/MAP降低,α-SMA染色减少,SM/胶原比值下降。
- 两个联合治疗组均改善勃起反应、海绵体α-SMA含量、磷酸化cJun阳性凋亡细胞数、Bcl-2/Bax比值和cJun磷酸化。
- CNCI+L+10.0J组上述改善趋势大于CNCI+L+1.0J组,但原文未报告统计学比较。
核心结论
- 本研究提示,联合抑制JNK和LIMK2可能通过恢复cJun/Bcl-2/Bax和LIMK2/Cofilin通路抑制海绵体凋亡和纤维化,从而在CN损伤后10天改善勃起功能。
研究设计与样本
- 研究将60只12周龄雄性Sprague-Dawley大鼠分为4组:假手术组、CNCI组、CNCI+L+1.0J组(10.0 mg/kg LIMK2抑制剂联合1.0 mg/kg JNK抑制剂)、CNCI+L+10.0J组(10.0 mg/kg LIMK2抑制剂联合10.0 mg/kg JNK抑制剂)。
- 术后10天评估勃起反应、组织学检查和Western blot。
主要发现
- CNCI组较假手术组最大ICP/MAP和AUC/MAP降低,α-SMA免疫组化染色减少,SM/胶原比值下降,磷酸化cJun阳性凋亡细胞增多,磷酸化LIMK2阳性成纤维细胞增多,cJun磷酸化增加,LIMK2/Cofilin磷酸化增加,Bcl-2/Bax比值下降,纤连蛋白表达增加。
- CNCI+L+1.0J组和CNCI+L+10.0J组均改善勃起反应、海绵体α-SMA含量、磷酸化cJun阳性凋亡细胞数、Bcl-2/Bax比值和cJun磷酸化。
- CNCI+L+10.0J组上述改善趋势大于CNCI+L+1.0J组。
- 两个治疗组均观察到SM/胶原比值、磷酸化LIMK2阳性成纤维细胞数、LIMK2/Cofilin磷酸化和纤连蛋白表达的纠正。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: To determine if combined administration of LIMK2 and JNK inhibitors in a rat model of erectile dysfunction induced by cavernosal nerve (CN) injury could restore erectile function by suppressing both cavernosal apoptosis and fibrosis via rectification of molecular pathways related to the structural alterations. METHODS: Sixty 12-week-old male Sprague-Dawley rats were categorized into 4 groups: (1) Sham-surgery (Sham) group, (2) CN-crush-injury (CNCI), (3) CNCI group (CNCI+L+1.0J) treated with a combination of 10.0 mg/kg LIMK2-inhibitors and low-dose (1.0 mg/kg) JNK-inhibitors, and (4) CNCI group (CNCI+L+10.0J) treated with a combination of 10.0 mg/kg LIMK2-inhibitors and a high dose (10.0 mg/kg) of JNK-inhibitors. Ten days after surgery, erectile response, histological-studies, and Western-blot was investigated. RESULTS: The CNCI group showed a reduced maximal ICP/MAP or AUC/MAP, decreased immunohistochemical-staining of α-SMA, decreased SM/collagen ratio, increased phospho-cJun-positive apoptotic cells, increased phospho-LIMK2-positive fibroblasts, increased cJun-phosphorylation, increased LIMK2/Cofilin-phosphorylation, decreased Bcl-2/Bax ratio, and increased protein-expression of fibronectin, compared to the Sham group. Both the CNCI+L+1.0J and CNCI+L+10.0J groups showed improvements in erectile-responses, content of cavernosal α-SMA, number of phospho-cJun-positive apoptotic cells, Bcl-2/Bax ratio and cJun phosphorylation. Their improvements in the CNCI+L+10.0J group showed a tendency to be greater than those in the CNCI+L+1.0J group. Also, in the 2 treatment groups, rectification of SM/collagen ratio, number of phospho-LIMK2-positive fibroblasts, LIMK2/Cofilin-phosphorylation, and protein-expression of fibronectin was observed. CONCLUSION: This study suggests that combined inhibition of JNK and LIMK2 may improve erectile function by suppressing cavernosal apoptosis and fibrosis via restoration of cJun/Bcl-2/Bax and LIMK2/Cofilin pathways at 10 days after CN injury.
引用
- Kim SW, Lee J, Park J, et al. Combination of LIM-kinase 2 and Jun Amino-terminal Kinase Inhibitors Improves Erectile Function in a Rat Model of Cavernous Nerve Injury. Urology. 2019. PMID: 31202856. doi:10.1016/j.urology.2019.06.005
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。